275.60
+5.35(+1.98%)
Currency In INR
Sector
Healthcare
Industry
Biotechnology
Employees
1132
First IPO Date
April 22, 2004
| Name | Title | Pay | Year Born |
| Dr. Stephan Fritschi Ph.D. | Chief Executive Officer of CARBOGEN AMCIS | 0 | N/A |
| Dr. Himani S. Dhotre | Chief Executive Officer of Projects & Operations | 0 | N/A |
| Mr. Jayesh A. Shah | Chief Executive Officer of Production | 0 | N/A |
| Ms. Deohooti Janmejay Vyas | Whole Time Director | 12M | 1951 |
| Mr. Harshil R. Dalal | Global Chief Financial Officer | 0 | N/A |
| Mr. Dharmesh Desai | GM of Secretarial & Legal | 0 | N/A |
| Ms. Shrima Gaurangbhai Dave | Compliance Officer & Company Secretary | 0 | N/A |
| Mr. . Gavin | Head of ESH | 0 | N/A |
| Mr. Paolo Armanino | Chief Operating Officer of Indian Operations | 0 | N/A |
| Mr. Arpit Janmejay Vyas | Global MD & Director | 0 | 1986 |
Dishman Carbogen Amcis Limited provides contract research and manufacturing services to the pharmaceutical industry worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It also manufactures and supplies bulk drugs, intermediates, phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D products, fine chemicals, hand and body wash, sanitisers, antiseptics, and various pharmaceutical and cosmetic-related products, as well as generic and highly potent active pharmaceutical ingredients. The company was incorporated in 1983 and is headquartered in Ahmedabad, India. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.